Zoetis Inc (ZTS)

62.58
0.28 0.45
NYSE : Health Care
Prev Close 62.30
Open 62.50
Day Low/High 62.17 / 62.64
52 Wk Low/High 45.28 / 62.48
Volume 2.83M
Avg Volume 3.07M
Exchange NYSE
Shares Outstanding 490.80M
Market Cap 30.15B
EPS 1.70
P/E Ratio 35.51
Div & Yield 0.42 (0.70%)

Latest News

Industrials Are Stalling, Techs Are Roaring: Cramer's 'Mad Money' Recap (Monday 5/15/17)

Industrials Are Stalling, Techs Are Roaring: Cramer's 'Mad Money' Recap (Monday 5/15/17)

Jim Cramer says investors are migrating toward sectors likely to have the biggest upside in the second half.

Zoetis Declares Third Quarter 2017 Dividend

Zoetis Declares Third Quarter 2017 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company's common stock of $0.

Zoetis Holds Annual Meeting Of Shareholders

Zoetis Holds Annual Meeting Of Shareholders

Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.

Forbes Names Zoetis One Of America's Best Employers For Second Year In A Row

Forbes Names Zoetis One Of America's Best Employers For Second Year In A Row

Zoetis Inc. (NYSE:ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the second year in a row.

Photo: Bill & Melinda Gates Foundation/Mulugeta Ayene

Photo: Bill & Melinda Gates Foundation/Mulugeta Ayene

Zoetis Inc. (NYSE:ZTS), the largest global animal health company, announced it will receive a US$14.

Oil Slide Puts Market Into Rotation: Cramer's 'Mad Money' Recap (Thursday 5/4/17)

Oil Slide Puts Market Into Rotation: Cramer's 'Mad Money' Recap (Thursday 5/4/17)

Gyrations hit market, as traders drop oil, buy safety.

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

The list begins with oil, but there's a ripple effect.

Market Recon: The Reflation Trade Still Lives, but Buckle Your Chinstrap

Market Recon: The Reflation Trade Still Lives, but Buckle Your Chinstrap

The Fed's intent is still as plain to see as it was late last year. This committee remains on mission.

Zoetis Announces First Quarter 2017 Results

Zoetis Announces First Quarter 2017 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2017 and reaffirmed its guidance for full year 2017.

Zoetis To Participate In The Bank Of America Merrill Lynch Health Care Conference

Zoetis To Participate In The Bank Of America Merrill Lynch Health Care Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 17, 2017, in Las Vegas, Nev.

Zoetis Has Received European Commission Marketing Authorization For Cytopoint (lokivetmab), The First Monoclonal Antibody (mAb) Therapy Approved In The European Union For Veterinary Use. Photo: Zoetis

Zoetis Has Received European Commission Marketing Authorization For Cytopoint (lokivetmab), The First Monoclonal Antibody (mAb) Therapy Approved In The European Union For Veterinary Use. Photo: Zoetis

Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European...

Zoetis To Acquire Nexvet Biopharma, An Innovator In Monoclonal Antibody Therapies For Companion Animals

Zoetis To Acquire Nexvet Biopharma, An Innovator In Monoclonal Antibody Therapies For Companion Animals

Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary ("Zoetis Bidco"), will purchase Nexvet, an innovator in monoclonal...

Nick Lachey's Dog, Wookie. Photo: Zoetis.

Nick Lachey's Dog, Wookie. Photo: Zoetis.

Zoetis Inc. (NYSE:ZTS), the leading global animal health company, today announced that music and television star Nick Lachey* is teaming up with the company to launch Your Animal Instinct , a program to help your...

Zoetis To Host Webcast And Conference Call On First Quarter 2017 Financial Results

Zoetis To Host Webcast And Conference Call On First Quarter 2017 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Halliburton, Schlumberger, Alcoa, Celgene:'Mad Money' Lightning Round (3/29/17)

Halliburton, Schlumberger, Alcoa, Celgene:'Mad Money' Lightning Round (3/29/17)

Jim Cramer is bullish on Halliburton, Schlumberger, Cypress Semiconductor and Celgene

This Market Loves Tech: Cramer's 'Mad Money' Recap (Wednesday 3/29/17)

This Market Loves Tech: Cramer's 'Mad Money' Recap (Wednesday 3/29/17)

Tech's organic growth and visibility has been apparent all year, says Jim Cramer.

Impax Gains 38% On CEO Appointment, Talk of Sale

Impax Gains 38% On CEO Appointment, Talk of Sale

The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.

Zoetis Moves Up In Analyst Rankings, Passing Alphabet

Zoetis Moves Up In Analyst Rankings, Passing Alphabet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #25 spot from Alphabet Inc , according to ETF Channel. Below is a chart of Zoetis Inc versus Alphabet Inc plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; GOOGL plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Zoetis To Participate In The Jefferies Animal Health Summit

Zoetis To Participate In The Jefferies Animal Health Summit

Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Animal Health Summit on Thursday, March 30, 2017, in New York, N.

Zoetis Now #193 Largest Company, Surpassing CBS Corp

Zoetis Now #193 Largest Company, Surpassing CBS Corp

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Zoetis Inc has taken over the #193 spot from CBS Corp , according to The Online Investor. Market capitalization is an important data point for investors to keep an eye on, for various reasons.

Zoetis To Participate In The Cowen And Company 37th Annual Health Care Conference

Zoetis To Participate In The Cowen And Company 37th Annual Health Care Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 37th Annual Health Care Conference on March 6, 2017, in Boston, Mass.

Zoetis Reports Earnings Beat, So Why Are Shares Plummeting?

Zoetis Reports Earnings Beat, So Why Are Shares Plummeting?

The New Jersey-based animal health company reported better-than-expected fourth quarter earnings Thursday, but shares fell 5%.

Animal Health Company Zoetis ZTS Reported Earnings Thursday

Animal Health Company Zoetis ZTS Reported Earnings Thursday

The company lowered guidance for FY 2017, which is likely to blame for the company's fall.

Bill Ackman Sells Zoetis, Holds Chipotle

Bill Ackman Sells Zoetis, Holds Chipotle

Ackman launched a winning activist campaign at Chipotle last year.

Market Recon: Crossed Wires? Hot Wire, Trip Wire, Live Wire

Market Recon: Crossed Wires? Hot Wire, Trip Wire, Live Wire

The consumer finally has some fun money to spare. That is the good news.

Zoetis Reports Fourth Quarter And Full Year 2016 Results

Zoetis Reports Fourth Quarter And Full Year 2016 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2016 and updated its guidance for the full year 2017.

What Buffett, Icahn and Other Billionaire Investors Are Buying in the Trump Era

What Buffett, Icahn and Other Billionaire Investors Are Buying in the Trump Era

Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.

The European Commission Has Granted Zoetis Inc. A License For Stronghold® Plus (selamectin/sarolaner), A Topical Combination Of Parasiticides That Treats Ticks, Fleas, Ear Mites, Lice And Gastrointestinal Nematodes And Prevents Heartworm Disease In Cats. (Photo: Zoetis)

The European Commission Has Granted Zoetis Inc. A License For Stronghold® Plus (selamectin/sarolaner), A Topical Combination Of Parasiticides That Treats Ticks, Fleas, Ear Mites, Lice And Gastrointestinal Nematodes And Prevents Heartworm Disease In Cats. (Photo: Zoetis)

Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company a license for Stronghold ® Plus (selamectin/sarolaner), a topical combination of parasiticides that treats ticks,...